Orally administered Lactobacillus plantarum reduces pro-inflammatory interleukin secretion in sera from Listeria monocytogenes infected mice

British Journal of Nutrition

Volumn 99, Issue 4, 2008, Pages 819-825

  Puertollano, Elena ^a   Puertollano, María A ^a   Cruz Chamorro, Lidia ^a   de Cienfuegos, Gerardo Álvarez ^a   Ruiz Bravo, Alfonso ^b   de Pablo, Manuel A ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Lactobacillus plantarum; Listeria monocytogenes; Pro inflammatory cytokines; Probiotics

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST RESISTANCE; IMMUNOMODULATION; INFECTION RESISTANCE; INFLAMMATION; LACTOBACILLUS PLANTARUM; LD 50; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER; MOUSE; NONHUMAN; SPLEEN; SURVIVAL RATE;

ANIMALS; CYTOKINES; INTERLEUKIN-1BETA; INTERLEUKIN-6; LACTOBACILLUS PLANTARUM; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PROBIOTICS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

LACTOBACILLUS PLANTARUM; LISTERIA MONOCYTOGENES; MUS;

EID: 40449083871     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507832533     Document Type: Article

References (37)

1. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M & Rowland I (1998). Functional food science and gastrointestinal physiology and function. Br J Nutr 80, S147-S171.
2. Erickson KL & Hubbard NE (20M) Probiotic immunomodulation in health and disease. J Nutr 130, 403S-409S.
3. Gill HS, Rutherfurd KJ, Prasad J & Gopal PK (2000) Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus, (HN017) and Bifidobacterium tactis (HN019). Brit J Nutr 83, 167-176.
4. Vaarala O (2003) Immunological effects of Probiotics with special reference to lactobacilli. Clin Exp Allergy 33, 1634-1640.
5. Alvarez-Olmos MI & Oberhelman RA (2001) Probiotic agents and infectious diseases: A modern perspective on a traditional therapy. Clin Infect Dis 32, 1567-1576.
6. Cross ML (2002) Microbes versus microbes: Immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol 34, 245-253.
7. Elahi S. Pang G, Ashman R & Clancy R (2005) Enhanced clearance of Candida albicans from the oral cavities of inice following oral administration of Lactobacillus acidophilus. Clin Exp Immunol 141, 29-36.
8. Perdigon G, de Macías ME, Alvarez S, Oliver G & de Ruiz Holgado AA (1986) Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 53, 404-410.
9. Hudault S, Lievin V, Bernet-Camard MF & Servin A (1997) Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 63, 513-518.
10. Isolauri E, Joensuu J, Suomalainen H, Luomala M & Vesikari T (1995) Improved immunogenicity of oral D X RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13, 310-312.
11. Reid G (2001) Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 73, 437S-443S.
12. Matsuzaki T & Chin J (2000) Modulating immune responses with probiotic bacteria. Immunol Cell Biol 78, 67-73.
13. Reid G & Burton J (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4, 319-324.
14. Kirjavainen PV, El-Nezami HS, Salminen SJ, Ahokas JT & Wright PF (1999) The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol Med Microbiol 26, 131-135.
15. Pessi T, Sutas Y, Hurme M & Isolauri E (2000) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30, 1804-1808.
16. Bengmark $ (2090) Bacteria for optimal health. Nutrition 16, 611-615.
17. van Reenen CA, Dicks LM & Chikindas ML (1998) Isolation, purification and partial characterization of plantaricin 423, a bacteriocin produced by Lactobacillus plantarum. J Appl Microbiol 84, 1131-1137.
18. Shen H, Tato CM & Fan X (1998) Listeria monocytogenes as a probe to study cell-mediated immunity. Currt Opin Immunol 10, 450-458.
19. Edelson BT & Unanue ER (2000) Immunity to Listeria infection. Curr Opin Immunol 12, 425-431.
20. Bujalance C, Jimenez-Valera M, Moreno E & Ruiz-Bravo A (2006) A selective differential medium for Lactobacillus plantarum. J Microbiol Meth 66, 572-575.
21. Chou L & Weimer B (1999) Isolation and characterization of acid- and bile-tolerant isolates from strains of Lactobacillus acidophilus. J Dairy Sci 82, 23-31.
22. Reid G, Jass J, Sebulsky MT & McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16, 658-672.
23. Holzapfel WH, Haberer P, Suel J, Schillinger U & Huis in't Veld JHJ (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41, 85-101.
24. Salminen S, Isolauri E & Salminen E (1996) Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges. Antonie Van Leeuwenhoek 70, 251-262.
25. Galdeano CM & Perdigon G (2004) Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J Appl Microbiol 97, 673-681.
26. Dunne C, O'Mahony L, Murphy L, et al. (2001) In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo findings. Am J Clin Nutr 73, 386S-392S.
27. Sato K (1984) Enhancement of host resistance against Listeria infection by Lactobacillus casei: Role of macrophages. Infect Immun 44, 445-451.
28. Mack DR, Michail S, Wei S, McDougall L & Hollingsworth MA (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276, G941-G950.
29. Bujalance C, Moreno E, Jimenez-Valera A & Ruiz-Bravo A (2007) A probiotics strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immuno-compromised mice. Int J Food Microbiol 113, 28-34.
30. Nomoto K, Miake S, Hashimoto S, Yokokura T, Mutai M, Yoshikai Y & Nomoto K (1985) Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei. J Clin Lab Immunol 17, 91-97.
31. Yokokura T, Nomoto & Shimizu T & NombtQ K (1986) Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei. Infect Immun 52, 156-160.
32. de Waard R, Garssen J, Bokkert GC & Vos JG (2002) Antagonistic activity of Lactobacillus casei strain Shirota against gastro-intestinal Listeria monocytogenes infection in rats. Int J Food Microbiol 73, 93-100.
33. Bernbom N, Licht TR, Saadbye P, Vogensen FK & Norrung B (2006) Lactobacillus plantarum inhibits growth of Listeria monocytogenes in an in vitro continuous flow gut model, but promotes invasion of L. monocytogenes in the gut of gnotobiotic rats. Int J Food Microbiol 108, 10-14.
34. Heumann D, Barras C, Severin A, Glauser MP & Tomasz A (1994) Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 62, 2715-2721.
35. Nicaise P, Gleizes A, Forestier F, Quero A & Labarre M (1993) Influence of intestinal bacterial flora on cytokine (IL-1, IL-6 and TNF-alpha) production by mouse peritoneal macrophages. Eur Cytokine Netw 4 133-138.
36. Pathmakanthan S, Li CK, Cowie J & Hawkey CJ (2004) Lactobacillus plantarum 299: Beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol Hepatol 19 166-173.
37. Di Giacinto C, Marinaro M, Sanchez M, Strober W & Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J Immunol 174, 3237-3246.